Cite
HARVARD Citation
Le Quellec, S. et al. (2019). Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins. Haemophilia. 25 (1), pp. e11-e18. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Le Quellec, S. et al. (2019). Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins. Haemophilia. 25 (1), pp. e11-e18. [Online].